Health technology reassessment and disinvestment instruments: a scoping review
Abstract Introduction Evidence on safety, clinical and cost-effectiveness forms a key part of Health Technology Assessment (HTA) value appraisal for new health technologies and is often used to inform reimbursement and market access decisions. However, value may depreciate over the lifecycle of tech...
Sparad:
| Huvudupphov: | , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2026-01-01
|
| Serie: | Health Research Policy and Systems |
| Länkar: | https://doi.org/10.1186/s12961-026-01444-x |
| Taggar: |
Inga taggar, Lägg till första taggen!
|